A股異動 | 易事特漲逾8% 廣東省國資委或成為公司實控人
格隆匯12月23日丨易事特(300376.SZ)打開漲停,現報4.99元,漲幅8.24%,暫成交1.47億元,最新總市值116億。公司20日公告稱,控股股東東方集團擬將其持有的公司6.957億股(29.99%的無限售流通股)轉讓予恆健控股公司,轉讓價4.43元/股。完成後,恆健控股公司將向公司全體股東發出不低於5%的部分要約收購。慧盟科技、何宇先生作為東方集團之一致行動人,承諾無條件放棄其持有的全部上市公司股份(合計1.874億股,佔公司總股本的8.0804%)所對應的表決權。交易完成後,恆健控股將成為公司的控股股東,廣東省國資委將成為公司的實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.